Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging solutions, announces today that two recent independent studies have confirmed that the company’s pioneering DX-S offline detector system delivers high quality diagnostic exposures with significantly reduced patient exposure dose. A study by the University Clinical Center of Giessen and Marburg in Germany evaluated the dose and quality performance of Agfa HealthCare’s DX-S system, compared to the performance of a 400 speed class screen/film system. The study involved 200 thoracic exposures from children . The second study, by the Friedrich Schiller University in Jena, Germany, covered larger children and adolescents and exposures using a chest phantom . The results were evaluated by five investigators. Both studies concluded that, with Agfa HealthCare’s DX-S system, the dose could be reduced by up to 50 percent, without reducing the diagnostic quality.
source: AGFA
No comments:
Post a Comment